Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Diglyceride has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Diglycerides sit at the oil and water interface because one part of the molecule is fat-soluble and the other is not. In an MCT emulsion or spray-dried MCT powder, that is what keeps the oil dispersed instead of separating. The pairing is formulation chemistry, not a claim about what either one does in the body.
Vitamin D3 is absorbed from mixed micelles in the small intestine, and those micelles are built from bile salts together with monoglycerides, diglycerides and free fatty acids released by lipase. A dose taken with essentially no fat is absorbed less completely than the same dose taken with fat. This is a general property of fat-soluble vitamin absorption rather than something specific to any branded emulsifier.
Tocopherols partition into the lipid phase and depend on micelle formation for uptake. Emulsifying diglycerides help disperse the oil phase so that lipase and bile can act on it. The effect is on delivery, not on tocopherol activity itself.
Beta-carotene is highly lipophilic and needs a lipid phase and micelle formation to cross the intestinal wall. Digestion products of dietary fat, including diglycerides, are part of that micelle. Note this is about how much gets absorbed, which is a delivery marker and not by itself an outcome.
Lutein in a fat-free matrix is poorly taken up compared with the same amount in an oil or emulsified base. Diglycerides contribute to the emulsified lipid phase that carries it. Again this describes absorption, not a downstream effect.
Powdered coenzyme Q10 in a dry capsule is absorbed poorly relative to the same dose held in a lipid or emulsified matrix. Mono- and diglycerides are common components of those matrices. The pairing is about getting the molecule into solution, and higher blood levels are a marker rather than a demonstrated clinical benefit.
In the CDP-choline branch of the Kennedy pathway, CDP-choline transfers its phosphocholine group onto diacylglycerol, and the product is phosphatidylcholine. That makes diacylglycerol a required substrate at that step, not an optional helper. This is settled cell biochemistry and does not depend on supplemental intake of either compound.
The enzyme joins the phosphocholine moiety from CDP-choline to the free hydroxyl of diacylglycerol. Both halves are needed for the reaction to run. This describes a biochemical pathway, and it does not follow that swallowing either compound raises membrane phospholipid synthesis in a person.
Diglycerides are the first product of triglyceride hydrolysis, so lipase activity sits directly upstream of them. Supplemental lipase in a digestive enzyme blend acts on the same bonds. The relationship is substrate and enzyme, which is why the two appear together in fat-digestion formulations.
Lecithin is a phospholipid emulsifier and mono- and diglycerides are non-ionic emulsifiers, and they stabilise different parts of an emulsion. Formulators combine them because the mixture holds an emulsion over a wider temperature and pH range than either alone. This is manufacturing practice and carries no claim about physiological effect.
Divalent calcium binds long-chain free fatty acids to form calcium soaps that are not absorbed and leave in the stool. High calcium taken with a fat load lowers the fraction of that fat which is absorbed, and it also increases faecal fat. Anyone using a lipid matrix specifically to carry a fat-soluble nutrient should know that a large simultaneous calcium dose works against that.
Emulsified omega-3 preparations exist because the oil phase otherwise separates and oxidises at the interface. Mono- and diglycerides are among the emulsifiers used to hold that dispersion. Emulsification also increases surface area for lipase, which is the mechanistic reason emulsified oils are often absorbed more completely.
Unformulated curcumin has very low oral bioavailability, and lipid-based or emulsified delivery is one of the standard responses. Diglyceride emulsifiers are part of building that vehicle. Higher plasma curcuminoid levels from such a system are a pharmacokinetic marker and are not the same thing as a clinical result.
Nothing specific on file for Diglyceride. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 3 we read for Diglyceride. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.